Literature DB >> 1567405

Estrogen and osteoarthritis: a study of synovial estradiol and estradiol receptor binding in human osteoarthritic knees.

C L Tsai1, T K Liu, T J Chen.   

Abstract

Estrogen appears to be a risk factor in knee osteoarthritis (OA). Results from 21 patients revealed that synovial estradiol level was highly related to the severity of OA. Increased estradiol receptor bindings in the medial compartment of the femoral condylar and tibia plateau cartilages were observed; the increase was significantly higher in the medial than in the lateral compartment (p less than 0.05). Although the synovial estradiol level was significantly lower in women with OA than in men with OA (p less than 0.01), postmenopausal women were hypothesized to be more susceptible to OA, since the possible existence of synovial testosterone might counteract the high estradiol synovial level in men, which results in a lower incidence of knee OA in men than in postmenopausal women. We suggest that excessive synovial estradiol and higher estradiol receptor bindings may be involved in the development of knee OA, particularly in postmenopausal women.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1567405     DOI: 10.1016/s0006-291x(05)80330-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Idiopathic condylar resorption of the temporomandibular joint in teenage girls (cheerleaders syndrome).

Authors:  L M Wolford
Journal:  Proc (Bayl Univ Med Cent)       Date:  2001-07

2.  Effect of estrogen on the expression of matrix metalloproteinase (MMP)-1, MMP-3, and MMP-13 and tissue inhibitor of metalloproternase-1 in osteoarthritis chondrocytes.

Authors:  Yun Jong Lee; Eun Bong Lee; Young Ee Kwon; Jung Jin Lee; Woo Shin Cho; Hyun A Kim; Yeong Wook Song
Journal:  Rheumatol Int       Date:  2003-04-09       Impact factor: 2.631

3.  Association of estrogen receptor gene polymorphism in patients with degenerative lumbar spondylolisthesise.

Authors:  Jung Sub Lee; Kuen Tak Suh; Jeung Il Kim; Jong Min Lim; Tae Sik Goh
Journal:  J Korean Neurosurg Soc       Date:  2011-11-30

4.  Does cartilage ERα overexpression correlate with osteoarthritic chondrosenescence? Indications from Labisia pumila OA mitigation.

Authors:  Iffah Nadhira Madzuki; Seng Fong Lau; Nor Aijratul Asikin Mohamad Shalan; Nur Iliyani Mohd Ishak; Suhaila Mohamed
Journal:  J Biosci       Date:  2019-09       Impact factor: 1.826

Review 5.  Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management.

Authors:  Stéphanie Gaillard; Vered Stearns
Journal:  Breast Cancer Res       Date:  2011-03-14       Impact factor: 6.466

6.  Sex Steroids and Osteoarthritis: A Mendelian Randomization Study.

Authors:  Yi-Shang Yan; Zihao Qu; Dan-Qing Yu; Wei Wang; Shigui Yan; He-Feng Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-23       Impact factor: 5.555

7.  Genetics in osteoarthritis.

Authors:  Mercedes Fernández-Moreno; Ignacio Rego; Vanessa Carreira-Garcia; Francisco J Blanco
Journal:  Curr Genomics       Date:  2008-12       Impact factor: 2.236

8.  The provocative lumbar facet joint.

Authors:  David S Binder; Devi E Nampiaparampil
Journal:  Curr Rev Musculoskelet Med       Date:  2009-03-31

9.  Estrogen receptor-alpha gene haplotype is associated with primary knee osteoarthritis in Korean population.

Authors:  Sheng-Yu Jin; Seung-Jae Hong; Hyung In Yang; Sang-do Park; Myung-Chul Yoo; Hee Jae Lee; Mee-Suk Hong; Hae-Jeong Park; Seo Hyun Yoon; Bum-Shik Kim; Sung-Vin Yim; Hun-Kuk Park; Joo-Ho Chung
Journal:  Arthritis Res Ther       Date:  2004-07-19       Impact factor: 5.156

10.  Surgical treatment of adolescent internal condylar resorption (AICR) with articular disc repositioning and orthognathic surgery in the growing patient--a pilot study.

Authors:  Trevor P Bodine; Larry M Wolford; Eustaquio Araujo; Donald R Oliver; Peter H Buschang
Journal:  Prog Orthod       Date:  2016-01-18       Impact factor: 2.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.